Acneiform lesions secondary to ZD1839, an inhibitor of the epidermal growth factor receptor
Magazine: Clinical and Experimental Dermatology
Date: Mar 1, 2004Medical Oncology Dermatology
Drugs that inhibit the epidermal growth factor receptor, such as ZD1839 or C225, are being used increasingly in the treatment of solid tumours.
This has led to the appearance of new secondary effects. We describe the case of a patient who presented with an acneiform eruption secondary to the administration of ZD1839. These lesions healed in a few days after stopping the drug.
CITATION Clin Exp Dermatol. 2004 Mar;29(2):138-40
you mayBE INTERESTED
The Clínica is the greater private hospital with technological equipment of Spain, all in a single center.
The professionals of the Clínica perform continuous research and training, always to the benefit of the patient.
Learn why we are different from other healthcare centers. Quality, speed, comfort and results.